期刊文献+

血清紧密连接蛋白1与甲状腺乳头状癌相关性研究 被引量:1

Relationship between serum claudin-1 level and papillary thyroid carcinoma
原文传递
导出
摘要 目的分析甲状腺结节患者血清紧密连接蛋白1(claudin-1,Cla-1)水平与甲状腺乳头状癌(papillary thyroid carcinoma,PTC)患病风险的相关性。方法回顾性分析345例甲状腺结节患者的临床资料,根据病理结果分为PTC组和良性甲状腺结节(benign thyroid nodule,BTN)组,统计分析组间血清Cla-1水平的差异及其与PTC患病风险的相关性。结果在PTC(n=225)和BTN(n=120)中血清Cla-1水平中位值为14.03(10.30,20.40)ng/mL。Wilcoxon符号秩检验显示血清Cla-1水平在PTC和BTN中的中位值[17.90(14.00,22.93)ng/mL比9.40(8.15,11.20)ng/mL]差异具有统计学意义(P<0.01)。随着血清Cla-1水平的升高,甲状腺结节中PTC患病率逐渐增加。受试者工作特征(ROC)曲线法分析,诊断PTC最佳的临界值为13.02 ng/mL,灵敏度为81.8%,特异度为89.2%,ROC曲线下面积(AUC)最大(AUC=0.944,P<0.01,95%CI 0.922~0.965)。Logistic回归分析发现血清Cla-1水平升高将增加PTC的风险,具有统计学意义(OR=4.334,95%CI 1.662~11.303,P=0.003)。血清Cla-1水平与性别、年龄、PTC累及部位、癌灶数目与直径、甲状腺外侵犯、淋巴结转移、TNM分期及合并桥本甲状腺炎组间比较差异具有统计学意义(P<0.01)。结论血清Cla-1水平可能是预测PTC风险的指标之一,并与体内PTC肿瘤细胞总量有关,而与肿瘤侵袭性行为无关。 Objective To analyze the correlation between serum claudin-1(Cla-1)level and the risk of papillary thyroid carcinoma(PTC)in patients with thyroid nodules.Methods The clinical data of 345 patients with thyroid nodules were retrospectively analyzed.According to the pathological results,they were divided into PTC group and benign thyroid nodule(BTN)group.The difference of serum Cla-1 level between 2 groups and its correlation with the risk of PTC were analyzed.Results In groups of PTC(n=225)and BTN(n=120),the median value of serum Cla-1 level was 14.03(10.30,20.40)ng/mL.The differences in the median value[17.90(14.00,22.93)ng/mL vs 9.40(8.15,11.20)ng/mL]of serum Cla-1 level in the PTC and BTN were statistically significant by Wilcoxon signed-rank test.The prevalence of PTC in thyroid nodules increased gradually with increasing of serum Cla-1 level.Receiver operated characteristic curve analysis showed that the best diagnostic cut-off value of the PTC was 13.02 ng/ml of which the sensitivity was 81.8%,the specificity was 89.2%,and the area under curve(AUC)was the largest(AUC=0.944,P<0.01,95%CI 0.922-0.965).Logistic regression analysis showed that elevated serum Cla-1 level increased the risk of PTC,and it was statistically significant(OR=4.334,95%CI 1.662-11.303,P=0.003).There was a significant correlation among the serum Cla-1 level and gender,age,location of involvement,number and diameter of cancer nodules,extracapsular invasion of thyroid,lymph node metastasis,tumor stage and combined with Hashimoto′s thyroiditis(P<0.01).Conclusion The serum level of Cla-1 may be one of risk factors to predict PTC,and it is related to the total amount of PTC tumor cells in vivo,but it was not related to the aggressive behavior of tumor.
作者 侯卫东 侯林虎 秦晓燕 禹远远 李进 刘艳晓 Hou Weidong;Hou Linhu;Qin Xiaoyan;Yu Yuanyuan;Li Jin;Liu Yanxiao(Department of Endocrinology,Pingdingshan Municipal First People′s Hospital,Pingdingshan 467099,China;Department of Clinical Laboratory,People′s Liberation Army Joint Logistics Support Force 989 Hospital,Pingdingshan 467099,China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2021年第11期979-984,共6页 Chinese Journal of Endocrinology and Metabolism
关键词 良性甲状腺结节 甲状腺乳头状癌 鉴别诊断 紧密连接蛋白1 Benign thyroid nodules Papillary thyroid carcinoma Differential diagnosis Claudin-1
  • 相关文献

参考文献8

二级参考文献54

  • 1Jin J, Machekano R, Mchenry CR. The utility of preoperative serumthyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg, 2010,199:294-297.
  • 2Gerschpacher M, Gibl C, Anderwald C, et al. Thyrotropin serum concentrations in patients with papillary thyroid microcanccrs. Thyroid, 2010,20:389-392.
  • 3Haymart MR, Glinberg SL, Liu J, et al. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol( Oxf), 2009,71:434-439.
  • 4Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy mayplay a protective role. Endocr Relat Cancer, 2009,16 : 1251-1260.
  • 5Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer, 2009,16 : 1065-1072.
  • 6Polyzos SA, Kita M, Efstathiadou Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol, 2008,134:953-960.
  • 7Kim SS, Lee B J, Lee JC, et al. Preoperative serum thyroid stimulating hormone levels in well differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single center expedence. Endocrine, 9011 10.9;Q-6.
  • 8Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery, 2003,134:946-954.
  • 9Pellegriti G,Frasca F,Regalbuto C. Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors[J].Journal of Cancer Epidemiol,2013.965212.
  • 10Siegel R,Naishadham D,Jemal A. Cancer statistics for Hispanics/Latinos,2012[J].CA:A Cancer Journal for Clinicians,2012.10-29.

共引文献194

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部